SCHEMBL7606386

SCHEMBL7606386

Nc1cccc(C(=O)Nc2ccc(C(=O)c3ccccc3)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.70
▸ MEN1 O00255 4/20 0.70
▸ NPC1 O15118 1/20 0.70
▸ RAB9A P51151 1/20 0.70
▸ PBRM1 Q86U86 1/20 0.67
▸ PTGS1 P23219 2/20 0.65
▸ FFAR1 O14842 1/20 0.64
▸ POLB P06746 3/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ HDAC1 Q13547 2/20 0.55
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ ULK1 O75385 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ APEX1 P27695 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ PTPN1 P18031 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11593046 0.92 PTGS1 (0.75) KMT2AMEN1NPC1RAB9APBRM1
SCHEMBL1352405 0.90 PTGS1 (0.68) KMT2AMEN1NPC1RAB9APBRM1
SCHEMBL2127722 0.90 PTGS1 (0.77) KMT2AMEN1NPC1RAB9APTGS1
SCHEMBL6866138 0.89 KMT2A (0.78) KMT2AMEN1NPC1RAB9APTGS1
SCHEMBL17744815 0.87 KMT2A (0.73) KMT2AMEN1PTGS1POLBKDM4E
SCHEMBL309467 0.87 PTGS1 (0.72) KMT2AMEN1PTGS1POLBKDM4E
SCHEMBL31171945 0.87 PTGS1 (0.72) KMT2AMEN1PTGS1POLBKDM4E
SCHEMBL6153699 0.86 PTGS1 (0.67) KMT2AMEN1NPC1RAB9APTGS1
Hydrochloric Acid SCHEMBL6153673 0.84 PTGS1 (0.65) KMT2AMEN1NPC1RAB9APTGS1
SCHEMBL6479304 0.84 PGR (0.72) KMT2AMEN1NPC1RAB9APTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 KMT2A 2379/4885MEN1 4038/4885NPC1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback